150 related articles for article (PubMed ID: 16209886)
1. Assessment of a new RNA stabilizing reagent (Tempus Blood RNA) for minimal residual disease in onco-hematology using the EAC protocol.
Prezeau N; Silvy M; Gabert J; Picard C
Leuk Res; 2006 May; 30(5):569-74. PubMed ID: 16209886
[TBL] [Abstract][Full Text] [Related]
2. The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia.
Thörn I; Olsson-Strömberg U; Ohlsen C; Jonsson AM; Klangby U; Simonsson B; Barbany G
Haematologica; 2005 Nov; 90(11):1471-6. PubMed ID: 16266893
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.
Beillard E; Pallisgaard N; van der Velden VH; Bi W; Dee R; van der Schoot E; Delabesse E; Macintyre E; Gottardi E; Saglio G; Watzinger F; Lion T; van Dongen JJ; Hokland P; Gabert J
Leukemia; 2003 Dec; 17(12):2474-86. PubMed ID: 14562124
[TBL] [Abstract][Full Text] [Related]
4. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
Gabert J; Beillard E; van der Velden VH; Bi W; Grimwade D; Pallisgaard N; Barbany G; Cazzaniga G; Cayuela JM; Cavé H; Pane F; Aerts JL; De Micheli D; Thirion X; Pradel V; González M; Viehmann S; Malec M; Saglio G; van Dongen JJ
Leukemia; 2003 Dec; 17(12):2318-57. PubMed ID: 14562125
[TBL] [Abstract][Full Text] [Related]
5. Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.
Müller MC; Merx K; Weisser A; Kreil S; Lahaye T; Hehlmann R; Hochhaus A
Leukemia; 2002 Dec; 16(12):2395-9. PubMed ID: 12454744
[TBL] [Abstract][Full Text] [Related]
6. [The genetic diagnosis of hematopoietic malignancy by polymerase chain reaction method].
Yokota H; Kitamura K
Rinsho Byori; 2000 Aug; 48(8):708-15. PubMed ID: 11064593
[TBL] [Abstract][Full Text] [Related]
7. Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia.
Müller MC; Hördt T; Paschka P; Merx K; La Rosée P; Hehlmann R; Hochhaus A
Acta Haematol; 2004; 112(1-2):30-3. PubMed ID: 15179002
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of the universal Russian reagent sets for real-time PCR and its application for molecular oncodiagnostic].
Manzeniuk OIu; Malakho SG; Pekhov VM; Kosorukova IS; Poltaraus AB
Mol Biol (Mosk); 2006; 40(2):349-56. PubMed ID: 16637276
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction.
Yamazaki J; Baba K; Goto-Koshino Y; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):321-31. PubMed ID: 18977540
[TBL] [Abstract][Full Text] [Related]
11. [Real-time PCR array for simultaneous detection of 37 kinds of fusion genes in leukemia].
Liu HX; Zhu P; Zhang Y; Wang HX; DU JW; Liu J; Gu JY; Ou Y
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):526-32. PubMed ID: 17459201
[TBL] [Abstract][Full Text] [Related]
12. Examination of stability of bone marrow blood RNA in the PAXgene tube.
Yamamoto T; Sekiyama A; Sekiguchi H; Yoshida T; Miyagi Y
Lab Hematol; 2006; 12(3):143-7. PubMed ID: 16950675
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of three rapid RNA extraction reagents: relevance for use in RT-PCR's and measurement of low level gene expression in clinical samples.
Chadderton T; Wilson C; Bewick M; Glück S
Cell Mol Biol (Noisy-le-grand); 1997 Dec; 43(8):1227-34. PubMed ID: 9489949
[TBL] [Abstract][Full Text] [Related]
14. [Using real-time polymerase chain reaction to quantitate bcr-abl mRNA].
Liu JX; Liu JL; Wang GJ
Ai Zheng; 2006 Nov; 25(11):1447-9. PubMed ID: 17094919
[TBL] [Abstract][Full Text] [Related]
15. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of minimal residual disease in acute myeloid leukemia.
Kern W; Schoch C; Haferlach T; Schnittger S
Crit Rev Oncol Hematol; 2005 Nov; 56(2):283-309. PubMed ID: 16213150
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide comparison of two RNA-stabilizing reagents for transcriptional profiling of peripheral blood.
Nikula T; Mykkänen J; Simell O; Lahesmaa R
Transl Res; 2013 Mar; 161(3):181-8. PubMed ID: 23138105
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of BCR-ABL fusion genes using a novel combined LUX primer, in-cell RT-PCR and flow cytometric method.
Shi Y; Li LZ; Sun JZ; Zhang T; Peng J; Xu CG
Ann Hematol; 2008 Jan; 87(1):35-41. PubMed ID: 17846772
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
Barragan E; Pajuelo JC; Ballester S; Fuster O; Cervera J; Moscardo F; Senent L; Such E; Sanz MA; Bolufer P
Clin Chim Acta; 2008 Sep; 395(1-2):120-3. PubMed ID: 18590714
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation.
Asare AL; Kolchinsky SA; Gao Z; Wang R; Raddassi K; Bourcier K; Seyfert-Margolis V
BMC Genomics; 2008 Oct; 9():474. PubMed ID: 18847473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
